Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma

Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma

The clinical impact of neutrophil-to-lymphocyte ratio (NLR) in predicting outcomes in hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization (TACE) remain unclear, and additional large-scale studies are required. This retrospective study evaluated outcomes in treatment-...

Full description

Bibliographic Details
Main Authors: Hee Ho Chu, Jin Hyoung Kim, Ju Hyun Shim, Dong Il Gwon, Heung-Kyu Ko, Ji Hoon Shin, Gi-Young Ko, Hyun-Ki Yoon, Nayoung Kim
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
hepatocellular carcinoma
intermediate-stage
transarterial chemoembolization
neutrophil-to-lymphocyte ratio
Online Access:https://www.mdpi.com/2072-6694/13/11/2830

Internet

https://www.mdpi.com/2072-6694/13/11/2830

Similar Items